Table 1.
Safety—serious and non-serious adverse events up to 6 months post intervention
| Caverstem intervention | 1.0 low dose | 1.0 high dose | 2.0 |
|---|---|---|---|
| Number of patients | 20 | 20 | 100 |
| Serious adverse event | 0 (0) | 0 (0) | 0 (0) |
| Loss of injection product (n) | 0 (0) | 0 (0) | 0 (0) |
| Total volume injected (mL) | 3 | 6 | 20 |
| Injection of allocated amount of product (n) | 20 (100) | 20 (100) | 100 (100) |
| Adverse event | n(%) | n(%) | n(%) |
| Pain at harvest sitea | 5 (25) | 7 (35) | 9 (9) |
| Pain at injection sitea | 6 (30) | 6 (30) | 5 (5) |
| Brushing at harvest sitea | 5 (25) | 5 (25) | 6 (6) |
| Bruising at injection sitea | 3 (15) | 4 (20) | 4 (4) |
| Negative impact on penisb | 0 (0) | 0 (0) | 0 (0) |
| Fevers | 0 (0) | 0 (0) | 0 (0) |
| Infection | 0 (0) | 0 (0) | 0 (0) |
aGreater than 24 h post procedure
bAs perceived by the patient